FCOP Breakthrough Targets Beta-Blockers in Britain's Rivers

Flooding, storm overflows and unseen chemical contamination now stem from the same underlying problem: treatment works designed for yesterday’s pollutants. A laboratory advance offers a move away from resignation and towards practical action.

Why beta-blockers evade treatment

Medicines transform lives, but residues enter waterways after they have been used. Beta-blockers, which are prescribed for high blood pressure and irregular heartbeats, withstand the gut, liver and lengthy sewer networks. This durability benefits patients, but it also allows the molecules to pass through filters intended to remove grit, fats and microbes. Activated carbon can deal with many contaminants, yet trace quantities of beta-blockers remain after conventional treatment. They accumulate in rivers. Fish behaviour changes, algae growth becomes disrupted, and subtle impacts build over time.

Water companies can reliably measure solids, nutrients and pathogens. Micropollutants require chemical analysis rather than mechanical monitoring alone. Every medicine behaves differently in real wastewater, while temperature, pH and organic matter all alter the outcome. The divide between laboratory chemistry and river health is continuing to grow.

A tailored material developed in Seoul

A research group led by Professor Yuhoon Hwang at Seoul National University of Science and Technology has reported a selective adsorbent designed specifically to capture beta-blockers. Known as a fluorinated covalent organic polymer, or FCOP, the material is a rigid, porous structure whose walls contain deliberately engineered chemistry. These walls engage drug molecules at several points. The intended benefits are rapid removal, selectivity and straightforward manufacture.

In tests, the FCOP removed about 70% of atenolol and more than 67% of metoprolol in under one minute.

At treatment works, where water flows continuously, speed is essential. Extended contact periods cost more, whereas rapid capture can cut both tank capacity and energy requirements. The researchers also describe a notable trend: removal rises sharply after concentrations pass a certain point.

The adsorption followed an S-shaped curve, signalling multilayer stacking rather than a single, thin coat on the surface.

How FCOP works at the molecular level

Its performance depends on three properties. First, fluorine atoms in the polymer form strong, directional interactions that help hold drug molecules in place. Second, the negatively charged surface attracts positively charged beta-blockers under typical water conditions. Third, because the material repels water, hydrophobic sections of drug molecules favour its surface rather than the surrounding liquid. Working together, these forces speed up capture as additional molecules arrive.

• Fluorine-based sites function as molecular hooks for the target medicines.
• A negative surface charge draws in cationic species present in many drugs.
• Hydrophobic areas encourage multilayer formation, increasing capacity at higher loads.

This delivers fast uptake at low and moderate concentrations, while retaining additional capacity for sudden peaks. Such a profile could suit works dealing with daytime highs, hospital discharges or storm-diluted surges.

What FCOP could mean for treatment works

According to the team, the polymer can be manufactured without rare catalysts, reducing obstacles to large-scale deployment. Engineers could use it in modular cartridges, apply it as a membrane coating or place it in polishing columns after biological treatment. By changing the chemistry of the framework, the same platform could be adjusted for other groups of medicines. This could provide routes to remove antidepressants, hormones and anti-inflammatories that also persist in rivers.

Built for precision capture, FCOP-style filters add a missing stage between classic treatment and tomorrow’s trace-pollutant standards.

Why this matters now in Britain

Public concern about river quality is increasing. Storm overflows attract the headlines, while micropollutants receive less public attention; nevertheless, regulators monitor them and scientists identify ecological changes associated with chronic exposure. Standard upgrades focus on phosphorus, ammonia and bacteria. A targeted end-of-pipe module for medicines could provide a practical addition without requiring entire works to be rebuilt.

Hospitals and pharmaceutical centres could install compact units on site, lowering the load before wastewater enters municipal networks. Rural treatment works could use portable cartridges matched to lower flows. Trials might begin at beta-blocker hotspots identified through monitoring.

Caveats, testing and major questions

Fluorinated materials rightly prompt questions about their stability and possible by-products. Treatment operators will require leaching tests, abrasion assessments and end-of-life strategies. The polymer must either be regenerated safely or replaced easily. Disposal of ash and recycling methods must not create PFAS-type risks. The early results concentrate on performance rather than long-term cycling. Pilot facilities should monitor capacity across repeated runs and assess fouling from natural organic matter.

Energy and cost assessments are equally important. A high-capacity adsorbent that works quickly could reduce pumping duration and the required footprint. Its real-world viability will depend on the cost per kilogram, its number of usable cycles and the chemicals needed for regeneration. Water companies will also need sensors that identify concentration peaks, allowing polishing stages to change operating modes efficiently.

From beta-blockers to wider clean-ups

The same design principles could be applied to other persistent contaminants. Hormones have different charges and ring structures, while antibiotics create complexes with metals and organic matter. Tailored polymers can be designed around each of these characteristics. A flexible toolkit is more effective than a universal filter. Laboratory collections of COFs and COPs already demonstrate potential against dyes, pesticides and per-oxygenated compounds. The key difficulties are scaling up synthesis, producing durable granules and maintaining a low pressure drop.

Pollutant class	Typical source	Observed impact	Targeted fix
Beta-blockers	Cardiovascular drugs	Fish behaviour changes; persistence	FCOP adsorption with charged, fluorinated sites
Antidepressants	Mood disorder treatments	Neurological effects in aquatic life	Tuned COPs with cation-exchange domains
Hormonal residues	Contraceptives, therapies	Endocrine disruption and skewed sex ratios	Affinity resins with steroid-binding pockets
Microplastics	Textiles, tyres, packaging	Vectors for toxins and biofilm formation	Fine screens plus coagulation and advanced oxidation

What to watch next

Three milestones will indicate whether this moves from a research paper into pipework. First are pilot studies using mixed wastewater, rather than laboratory water alone, to test speed under genuine loads. Second is regeneration performance after dozens of cycles, including any loss of capacity. Third is compatibility with existing processes such as ozonation, UV and biologically activated carbon, enabling works to combine methods without unintended reactions.

Practical measures for water companies

• Identify pharmaceutical hotspots through high-frequency sampling near hospitals and care homes.
• Trial modular adsorbers after tertiary treatment for four seasons to reflect changing conditions.
• Establish regeneration procedures that limit solvent use and monitor any fluorine release.
• Combine targeted adsorbers with bio-based polishing to lower operating costs.

A broader view of river health

Trace chemicals seldom act in isolation. Nutrients, metals and microplastics interact with pharmaceuticals, altering their toxicity and movement. Beta-blockers may attach to microplastic surfaces and travel downstream with them. Pesticide surges after rainfall can happen alongside Monday peaks in drug residues. Monitoring that records timing and mixtures provides a more accurate view than isolated snapshots.

People can also help to reduce these loads. Safe medicine take-back schemes prevent pills from being flushed away. GP advice on dosage can reduce unused medicines. Everyday actions can limit fibre shedding and tyre dust, both of which carry absorbed chemicals into drains. These measures do not replace technological upgrades, but together they reduce the pressure on treatment works.

Precision filtration closes a long-standing gap: it targets what biology misses, without rebuilding whole facilities.

Key terms, simply explained

• Adsorption: molecules adhere to a surface rather than passing through it.
• Sigmoidal uptake: uptake begins slowly, rises sharply and then levels off as sites and layers become full.
• Covalent organic polymer: a rigid network of organic building blocks connected by strong bonds.
• Hydrophobic effect: water-repelling molecules favour surfaces or one another over the liquid surrounding them.

This Korean advance will not solve river health by itself. However, it gives engineers a rapid, targeted option for a difficult class of chemicals. With pilot testing, robust safeguards and intelligent deployment, it could help shift the balance towards cleaner, safer water.